Top

Published in:

01-04-2017 | Original Article

Vehicle type affects filling of fractional laser-ablated channels imaged by optical coherence tomography

Authors: Uffe Høgh Olesen, Mette Mogensen, Merete Haedersdal

Published in: Lasers in Medical Science | Issue 3/2017

Abstract

Ablative fractional laser (AFXL) is an emerging method that enhances topical drug delivery. Penetrating the skin in microscopic, vertical channels, termed microscopic treatment zones (MTZs), the fractional technique circumvents the skin barrier and allows increased uptake of topically applied drugs. This study aims to elucidate the impact of vehicle type on the filling of MTZs from application of liquid, gel, and cream vehicles. Ex vivo pig skin was exposed to 10,600 nm fractional CO₂ laser at 5% density, 120 μm beam diameter, and fluences of 40 and 80 mJ/microbeam (mJ/mb). Six repetitions were performed for each of six interventions (2 fluences and 3 vehicle types, n = 36). MTZ dimensions and filling by vehicle type were evaluated by optical coherence tomography, using blue tissue dye as a contrast-enhancing agent. Outcome measure was degree of MTZ filling assessed as percentages of empty, partially filled, and completely filled MTZs (108–127 MTZs/intervention analyzed) and evaluated statistically using Kruskal-Wallis and Dunn’s tests. MTZs reached mid-dermal levels of 225 μm (40 mJ/mb) and 375 μm (80 mJ/mb) penetration depths (p < 0.0001). Filling of MTZs depended on type of applied vehicle. At 80 mJ/mb, liquid (67% completely filled, p < 0.01) and gel (60%, p < 0.05) formulations filled MTZs significantly better than cream formulation (31%). At 40 mJ/mb, liquid and gel formulations filled 90% (p < 0.05) and 77% (p > 0.05) of MTZs completely versus 55% for cream formulation. Thus, filling was overall greater for more superficial MTZs. In conclusion, vehicle type affects filling of MTZs, which may be of importance for AFXL-assisted drug delivery.

Haedersdal M, Erlendsson AM, Paasch U, Anderson RR (2016) Translational medicine in the field of ablative fractional laser assisted drug delivery: a critical review from basics to current clinical status. J Am Acad Dermatol 74:981–1004CrossRefPubMed

Hantash BM, Bedi VP, Chan KF, Zachary CB (2007) Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers Surg Med 39:87–95CrossRefPubMed

Skovbølling Haak C, Illes M, Paasch U, Hædersdal M (2011) Histological evaluation of vertical laser channels from ablative fractional resurfacing: an ex vivo pig skin model. Lasers Med Sci 26:465–471CrossRefPubMed

Hsiao CY, Sung HC, Hu S, Huang YL, Huang CH (2016) Fractional CO(2) laser pretreatment facilitates transdermal delivery of two vitamin C derivatives. Molecules 21

Hædersdal M, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, Anderson RR (2010) Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med 42:113–122CrossRefPubMed

Wenande E, Olesen UH, Nielsen MM, Janfelt C, Hansen SH, Anderson RR, Haedersdal M (2016) Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake. Expert Opin Drug Deliv 28:1–11

Taudorf EH, Lerche CM, Erlendsson AM, Philipsen PA, Hansen SH, Janfelt C, Paasch U, Anderson RR, Haedersdal M (2016) Fractional laser-assisted drug delivery: laser channel depth influences biodistribution and skin deposition of methotrexate. Lasers Surg Med 48:519–529CrossRefPubMed

Taudorf EH, Lerche CM, Vissing AC, Philipsen PA, Hannibal J, D’Alvise J, Hansen SH, Janfelt C, Paasch U, Anderson RR, Haedersdal M (2015) Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation. Expert Opin Drug Deliv 12:1059–1069CrossRefPubMed

Mahmoud BH, Burnett C, Ozog D (2015) Prospective randomized controlled study to determine the effect of topical application of botulinum toxin A for crow’s feet after treatment with ablative fractional CO2 laser. Dermatol Surg 41 Suppl 1:S75–S81CrossRefPubMed

10.

Chen X, Shah D, Kositratna G, Manstein D, Anderson RR, Wu MX (2012) Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J Control Release 159:43–51CrossRefPubMedPubMedCentral

11.

Bhatta AK, Keyal U, Huang X, Zhao JJ (2016) Fractional carbon-dioxide (CO2) laser-assisted topical therapy for the treatment of onychomycosis. J Am Acad Dermatol 74:916–923CrossRefPubMed

12.

Meesters AA, Bakker MM, de Rie MA, Wolkerstorfer A (2016) Fractional CO2 laser assisted delivery of topical anesthetics: a randomized controlled pilot study. Lasers Surg Med 48:208–211CrossRefPubMed

13.

Park SM, Kim GW, Mun JH, Song M, Kim HS, Kim BS, Kim MB, Ko HC (2016) Fractional laser-assisted topical imiquimod 5% cream treatment for recalcitrant common warts in children: a pilot study. Dermatol Surg 42:1340–1346CrossRefPubMed

14.

Song HS, Jung SE, Jang YH, Kang HY, Lee ES, Kim YC (2015) Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis. Photodermatol Photoimmunol Photomed 31:296–301CrossRefPubMed

15.

Tian T, Luo Y, Jiang T, Dong Y, Yu A, Chen H, Gao X, Li Y (2016) Clinical effect of ablative fractional laser-assisted topical anesthesia on human skin: a randomized pilot study. J Cosmet Laser Ther 18:409–412CrossRefPubMed

16.

Banzhaf CA, Wind BS, Mogensen M, Meesters AA, Paasch U, Wolkerstorfer A, Haedersdal M (2016) Spatiotemporal closure of fractional laser-ablated channels imaged by optical coherence tomography and reflectance confocal microscopy. Lasers Surg Med 48:157–165CrossRefPubMed

17.

Sattler EC, Poloczek K, Kästle R, Welzel J (2013) Confocal laser scanning microscopy and optical coherence tomography for the evaluation of the kinetics and quantification of wound healing after fractional laser therapy. J Am Acad Dermatol 69:e165–e173CrossRefPubMed

18.

Tsai MT, Yang CH, Shen SC, Lee YJ, Chang FY, Feng CS (2013) Monitoring of wound healing process of human skin after fractional laser treatments with optical coherence tomography. Biomed Opt Express 4:2362–2375CrossRefPubMedPubMedCentral

19.

Sattler E, Kästle R, Welzel J (2013) Optical coherence tomography in dermatology. J Biomed Opt 18:061224CrossRefPubMed

20.

Mogensen M, Morsy HA, Thrane L, Jemec GB (2008) Morphology and epidermal thickness of normal skin imaged by optical coherence tomography. Dermatology 217:14–20CrossRefPubMed

21.

Gambichler T, Jaedicke V, Terras S (2011) Optical coherence tomography in dermatology: technical and clinical aspects. Arch Dermatol Res 303:457–473CrossRefPubMed

22.

Mogensen M, Joergensen TM, Nürnberg BM, Morsy HA, Thomsen JB, Thrane L, Jemec GB (2009) Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists. Dermatol Surg 35:965–972CrossRefPubMed

23.

Ring HC, Themstrup L, Banzhaf CA, Jemec GB, Mogensen M (2016) Dynamic optical coherence tomography capillaroscopy: a new imaging tool in autoimmune connective tissue disease. JAMA Dermatol 152

24.

Lee WR, Shen SC, Aljuffali IA, Li YC, Fang JY (2014) Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation. Pharm Res 31:382–393CrossRefPubMed

25.

Forster B, Klein A, Szeimies RM, Maisch T (2010) Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol 19:806–812CrossRefPubMed

26.

Bachhav YG, Heinrich A, Kalia YN (2011) Using laser microporation to improve transdermal delivery of diclofenac: increasing bioavailability and the range of therapeutic applications. Eur J Pharm Biopharm 78:408–414CrossRefPubMed

27.

Bachhav YG, Summer S, Heinrich A, Bragagna T, Böhler C, Kalia YN (2010) Effect of controlled laser microporation on drug transport kinetics into and across the skin. J Control Release 146:31–36CrossRefPubMed

28.

Barbero AM, Frasch HF (2009) Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 23:1–13CrossRefPubMed

29.

Jakasa I, Kezic S (2008) Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man. Hum Exp Toxicol 27:281–288CrossRefPubMed

30.

Kim W, Applegate BE (2015) In vivo molecular contrast OCT imaging of methylene blue. Opt Lett 40:1426–1429CrossRefPubMed

Title: Vehicle type affects filling of fractional laser-ablated channels imaged by optical coherence tomography
Authors: Uffe Høgh Olesen
Mette Mogensen
Merete Haedersdal
Publication date: 01-04-2017
Publisher: Springer London
Published in: Lasers in Medical Science / Issue 3/2017
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-017-2168-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Vehicle type affects filling of fractional laser-ablated channels imaged by optical coherence tomography

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia

Efficacy and safety of far infrared radiation in lymphedema treatment: clinical evaluation and laboratory analysis

The effect of different cleaning methods on the surface and temperature of failed titanium implants: an in vitro study

Investigation of photobiomodulation potentiality by 635 and 809 nm lasers on human osteoblasts

Dynamic optical absorption characteristics of blood after slow and fast heating

Clinical effectiveness of low-level laser treatment on peripheral somatosensory neuropathy